Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keren Isaev

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Personalized Medicine|May 15, 2018
Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genomeJunjie Hua, Jennifer Lu, Keren Isaev, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Orthrus: Towards Evolutionary and Functional RNA Foundation ModelsPhilip Fradkin, Ruian Shi, Keren Isaev, et al.
Nature Methods|April 17, 2026
Orthrus: toward evolutionary and functional RNA foundation modelsPhilip Fradkin, Ruian Ian Shi, Taykhoom Dalal, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolboxMegan D Schertzer, Andrew Stirn, Keren Isaev, et al.
Haematologica|June 23, 2022
In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy ProgramKeren Isaev, Ting Liu, Mehran Bakhtiari, et al.
Cell Reports|October 23, 2021
Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomasKeren Isaev, Lingyan Jiang, Shuai Wu, et al.
Nature Communications|July 29, 2025
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolboxMegan D Schertzer, Andrew Stirn, Keren Isaev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaKit I Tong, Sharon Yoon, Keren Isaev, et al.
Haematologica|August 21, 2020
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphomaKeren Isaev, Daisuke Ennishi, Laura Hilton, et al.
Cancer Research|July 12, 2019
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in GlioblastomaRohit Sachdeva, Megan Wu, Sandra Smiljanic, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Personalized Medicine|May 15, 2018
Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genomeJunjie Hua, Jennifer Lu, Keren Isaev, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Orthrus: Towards Evolutionary and Functional RNA Foundation ModelsPhilip Fradkin, Ruian Shi, Keren Isaev, et al.
Nature Methods|April 17, 2026
Orthrus: toward evolutionary and functional RNA foundation modelsPhilip Fradkin, Ruian Ian Shi, Taykhoom Dalal, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolboxMegan D Schertzer, Andrew Stirn, Keren Isaev, et al.
Haematologica|June 23, 2022
In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy ProgramKeren Isaev, Ting Liu, Mehran Bakhtiari, et al.
Cell Reports|October 23, 2021
Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomasKeren Isaev, Lingyan Jiang, Shuai Wu, et al.
Nature Communications|July 29, 2025
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolboxMegan D Schertzer, Andrew Stirn, Keren Isaev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaKit I Tong, Sharon Yoon, Keren Isaev, et al.
Haematologica|August 21, 2020
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphomaKeren Isaev, Daisuke Ennishi, Laura Hilton, et al.
Cancer Research|July 12, 2019
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in GlioblastomaRohit Sachdeva, Megan Wu, Sandra Smiljanic, et al.
Pageof 2